Integrated in silico design, synthesis, and biological evaluation of a brominated betulin derivative with anticancer and antibacterial activities
Bioorganic Chemistry · 2026-07 · 176 · 109871
DOI: 10.1016/j.bioorg.2026.109871 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioorganic Chemistry, 2026-07. Verfasst von Agata Serrafi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Immunochemistry, Medical University of Wroclaw, 50-369 Wrocław, Poland. Electronic address: agata.serrafi@umed.wroc.pl. Hauptthemen laut MEDLINE: Antineoplastic Agents, Anti-Bacterial Agents, Drug Design, Triterpenes. Die Arbeit nennt 64 Literaturangaben.
Abstract (Originalsprache)
Betulin is a promising starting compound, but previous chemical modifications often yielded mixtures of isomers with unpredictable activity. To address this, we employed an integrated strategy combining in silico design with controlled chemical synthesis to create a novel, pure derivative. Our key innovation is the regioselective bromination at the C-30 position of the betulin scaffold. We obtained a unique derivative with a purity of >99% (confirmed by HPLC), which eliminates the problem of isomeric variability. Molecular docking predicted favorable binding and a dual mechanism of action against melanoma targets: BRAF kinase and Caspase-3 (CASP3). Pharmacokinetic (ADMET) profiling suggested high intestinal absorption and low toxicity, despite an increase in lipophilicity (LogP from 7.00 to 9.29). Biological studies demonstrated superior and selective cytotoxicity against metastatic melanoma cells (Lu1205 and Me45), with minimal toxicity to normal fibroblasts (NHDF IC50 > 25 μg/mL). This resulted in a high Selectivity Index (SI >1.0). The mechanism of action involves the induction of apoptosis and the generation of reactive oxygen species (ROS). Furthermore, the compound exhibited selective antibacterial activity against Staphylococcus aureus (MIC 15.6 μg/mL).In summary, the highly pure C-30 brominated betulin derivative is a promising, multi-target therapeutic candidate for melanoma treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Immunochemistry, Medical University of Wroclaw, 50-369 Wrocław, Poland. Electronic address: agata.serrafi@umed.wroc.pl.
- Department of Biophysics and Neuroscience, Wroclaw Medical University, 50-367 Wroclaw, Poland. Electronic address: anna.palko-labuz@umw.edu.pl.
- Faculty of Chemistry, Wroclaw University of Science and Technology, 50-370 Wroclaw, Poland.
- Laboratory of Integrative Biology, Department of Biology, Faculty of Sciences Aïn Chock, Hassan II University of Casablanca, Route El Jadida, BP 5366 Maarif, Casablanca 20100, Morocco.
- Department of Biophysics and Neuroscience, Wroclaw Medical University, 50-367 Wroclaw, Poland. Electronic address: kamila.sroda-pomianek@umw.edu.pl.
Zitieren
APA
Serrafi, A., Palko-Łabuz, A., Grela, E., Aguerd, A., Chegdani, F., & Środa-Pomianek, K. (2026). Integrated in silico design, synthesis, and biological evaluation of a brominated betulin derivative with anticancer and antibacterial activities. Bioorganic Chemistry, 176, 109871. https://doi.org/10.1016/j.bioorg.2026.109871
Vancouver
Serrafi A, Palko-Łabuz A, Grela E, Aguerd A, Chegdani F, Środa-Pomianek K. Integrated in silico design, synthesis, and biological evaluation of a brominated betulin derivative with anticancer and antibacterial activities. Bioorganic Chemistry. 2026;176:109871. doi:10.1016/j.bioorg.2026.109871
BibTeX
@article{Serrafi2026,
author = {Serrafi, Agata and Palko-Łabuz, Anna and Grela, Ewa and Aguerd, Ali and Chegdani, Fatima and Środa-Pomianek, Kamila},
title = {Integrated in silico design, synthesis, and biological evaluation of a brominated betulin derivative with anticancer and antibacterial activities},
journal = {Bioorganic Chemistry},
year = {2026},
volume = {176},
pages = {109871},
doi = {10.1016/j.bioorg.2026.109871}
}
EUVIMED